The Company plans to provide updated revenue and adjusted operating expenses guidance during its third quarter 2025 earnings call, taking into account the factors discussed in this press release.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SGHT:
- Sight Sciences price target lowered to $4 from $4.50 at Citi
- Sight Sciences Amends Loan Agreement with Hercules
- Sight Sciences announces publication of results on OMNI Surgical System
- Sight Sciences: Balancing Resilience in Glaucoma Market with Reimbursement Challenges – Hold Rating Justified
- Needham medtech & diagnostics analysts hold analyst/industry conference call